recombinant lipase (CDX-7108) / Codexis, Nestle 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  recombinant lipase (CDX-7108) / Codexis, Nestle
    Phase classification:  Oral CDX-7108 in Healthy Adults and EPI Subjects (clinicaltrials.gov) -  Sep 21, 2024   
    P1,  N=54, Completed, 
    Phase classification: P1a/1b --> P1
  • ||||||||||  recombinant lipase (CDX-7108) / Codexis, Nestle
    Trial completion, Trial completion date, Trial primary completion date:  Oral CDX-7108 in Healthy Adults and EPI Subjects (clinicaltrials.gov) -  Apr 26, 2023   
    P1a/1b,  N=54, Completed, 
    Phase classification: P1a/1b --> P1 Recruiting --> Completed | Trial completion date: Jan 2024 --> Mar 2023 | Trial primary completion date: Jun 2023 --> Mar 2023
  • ||||||||||  recombinant lipase (CDX-7108) / Codexis, Nestle
    Trial completion date, Trial primary completion date:  Oral CDX-7108 in Healthy Adults and EPI Subjects (clinicaltrials.gov) -  Oct 26, 2022   
    P1a/1b,  N=58, Recruiting, 
    Recruiting --> Completed | Trial completion date: Jan 2024 --> Mar 2023 | Trial primary completion date: Jun 2023 --> Mar 2023 Trial completion date: Feb 2023 --> Jan 2024 | Trial primary completion date: Jul 2022 --> Jun 2023
  • ||||||||||  recombinant lipase (CDX-7108) / Codexis, Nestle
    Enrollment open:  Oral CDX-7108 in Healthy Adults and EPI Subjects (clinicaltrials.gov) -  Dec 17, 2021   
    P1a/1b,  N=58, Recruiting, 
    Trial completion date: Feb 2023 --> Jan 2024 | Trial primary completion date: Jul 2022 --> Jun 2023 Not yet recruiting --> Recruiting